Literature DB >> 18496847

Transcranial color doppler study for reversible cerebral vasoconstriction syndromes.

Shih-Pin Chen1, Jong-Ling Fuh, Feng-Chi Chang, Jiing-Feng Lirng, Ben-Chang Shia, Shuu-Jiun Wang.   

Abstract

OBJECTIVE: Reversible cerebral vasoconstriction syndromes (RCVS) are characterized by thunderclap headaches and reversible cerebral vasoconstrictions. No systematic studies on cerebral hemodynamics have been published.
METHODS: Patients with RCVS were consecutively recruited. Sequential transcranial color-coded sonography studies were performed on the middle cerebral artery (MCA) for 3 months. Mean flow velocities (V(MCA)) and Lindegaard Index (LI) were recorded and compared with those of controls.
RESULTS: Thirty-two patients (all female; average age, 49.7 +/- 6.8 years) were enrolled. Four developed of reversible posterior leukoencephalopathy syndrome, and two of them, ischemic strokes. One hundred and twenty-six sonography studies were performed on 57 eligible MCAs. The mean maximum V(MCA) (109.5 +/- 30.8 cm/sec) and LI (2.2 +/- 0.7) of RCVS patients exceeded those of controls (V(MCA): 66.3 +/- 9.5 cm/sec, p < 0.001; LI: 1.4 +/- 0.3, p < 0.001). The V(MCA) and LI levels were still at their plateau at the mean time (day 22 after headache onset) of headache resolution. Fifteen (46.9%) patients had V(MCA) exceeding 120 cm/sec, and 5 (16%) had LI exceeding 3. Patients fulfilling the criteria of subarachnoid hemorrhage mild vasospasm (n = 4; 13%), that is, both V(MCA) greater than 120 cm/sec and LI greater than 3, had a greater risk of posterior leukoencephalopathy (75 vs 4%; p = 0.003) and ischemic strokes (50 vs 0%; p = 0.01) than those without.
INTERPRETATION: Patients with RCVS experienced prolonged vasoconstriction, making the risk for posterior leukoencephalopathy and ischemic strokes outlast headache resolution. Patients fulfilling mild vasospasm criteria for subarachnoid hemorrhage carry a high risk.

Entities:  

Mesh:

Year:  2008        PMID: 18496847     DOI: 10.1002/ana.21384

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  43 in total

1.  Multimodal imaging of reversible cerebral vasoconstriction syndrome: a series of 6 cases.

Authors:  C P Marder; M M Donohue; J R Weinstein; K R Fink
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-15       Impact factor: 3.825

2.  55-Year-old man with thunderclap headache.

Authors:  Srijana Zarkou; Esma Dilli; David W Dodick
Journal:  Mayo Clin Proc       Date:  2010-07       Impact factor: 7.616

3.  Cerebral-autoregulatory dysfunction syndrome.

Authors:  Ravindra Kumar Garg; Hardeep Singh Malhotra; Tushar B Patil; Avinash Agrawal
Journal:  BMJ Case Rep       Date:  2013-12-05

4.  Intra-Arterial Verapamil Treatment in Oral Therapy-Refractory Reversible Cerebral Vasoconstriction Syndrome.

Authors:  J M Ospel; C H Wright; R Jung; L L M Vidal; S Manjila; G Singh; D V Heck; A Ray; K A Blackham
Journal:  AJNR Am J Neuroradiol       Date:  2019-12-26       Impact factor: 3.825

5.  Peripartum angiopathy with simultaneous sinus venous thrombosis, cervical artery dissection and cerebral arterial vasoconstriction.

Authors:  Markus Hoeren; Claudia Hader; Sandra Strümpell; Cornelius Weiller; Matthias Reinhard
Journal:  J Neurol       Date:  2011-05-04       Impact factor: 4.849

6.  Thunderclap headache and benign angiopathy of the central nervous system: a common pathogenetic basis.

Authors:  E Agostoni; A Rigamonti; A Aliprandi
Journal:  Neurol Sci       Date:  2011-05       Impact factor: 3.307

7.  Point-of-care ultrasound in the critically ill pregnant or postpartum patient: what every intensivist should know.

Authors:  Pablo Blanco; Anselmo Abdo-Cuza
Journal:  Intensive Care Med       Date:  2019-07-03       Impact factor: 17.440

8.  Reversible cerebral vasoconstriction syndromes: what the cardiologist should know.

Authors:  Aneesh B Singhal
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-03

Review 9.  Thunderclap headache.

Authors:  Esma Dilli
Journal:  Curr Neurol Neurosci Rep       Date:  2014-04       Impact factor: 5.081

Review 10.  Abrupt-onset severe headaches.

Authors:  Yo-El S Ju; Todd J Schwedt
Journal:  Semin Neurol       Date:  2010-03-29       Impact factor: 3.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.